Abstract

It is highly desirable to predict the progression of Alzheimer's disease (AD) of patients [e.g., to predict conversion of mild cognitive impairment (MCI) to AD], especially longitudinal prediction of AD is important for its early diagnosis. Currently, most existing methods predict different clinical scores using different models, or separately predict multiple scores at different future time points. Such approaches prevent coordinated learning of multiple predictions that can be used to jointly predict clinical scores at multiple future time points. In this paper, we propose a joint learning method for predicting clinical scores of patients using multiple longitudinal prediction models for various future time points. Three important relationships among training samples, features, and clinical scores are explored. The relationship among different longitudinal prediction models is captured using a common feature set among the multiple prediction models at different time points. Our experimental results based on the Alzheimer's disease neuroimaging initiative (ADNI) database shows that our method achieves considerable improvement over competing methods in predicting multiple clinical scores.

Highlights

  • Alzheimer’s disease (AD) imposes heavy social-economic burdens on society (Fan et al, 2008; Alzheimer’s Association, 2014; Shi et al, 2015), and patients experience tremendous cognitive decline throughout progression of the AD disease

  • We introduce a designed loss function to jointly predict the patients’ clinical scores at multiple future time points, condensing the common information shared by data from different time points and permitting the selection of the most meaningful features for multiple prediction tasks

  • Alzheimer’s disease neuroimaging initiative (ADNI) is the collective effort of many co-investigators from a broad range of academic institutions and private corporations, and subjects have been recruited from over 50 sites across the US and Canada. 800 adults aged 55–90 were recruited to participate in this research, which includes approximately 200 cognitively normal older individuals followed for 3 years, 400 people with mild cognitive impairment (MCI) followed for 3 years, and 200 people with early AD followed for 2 years

Read more

Summary

Introduction

Alzheimer’s disease (AD) imposes heavy social-economic burdens on society (Fan et al, 2008; Alzheimer’s Association, 2014; Shi et al, 2015), and patients experience tremendous cognitive decline throughout progression of the AD disease. Modeling disease progression based on cognitive decline in longitudinal analysis has been widely investigated in the neuroimaging field (Fan et al, 2008; Davatzikos et al, 2010; Stonnington et al, 2010; Wang et al, 2010; Hinrichs et al, 2011). Longitudinal Analysis for Disease Progression with traditional structural magnetic resonance imaging (MRI) (Davatzikos et al, 2001, 2008; Dickerson et al, 2001; Gaser et al, 2001; Leow et al, 2006; Jack et al, 2008; Vemuri et al, 2008; Frisoni et al, 2010; Stonnington et al, 2010; Wang et al, 2016a), diffusion-weighted MRI (Jin et al, 2015, 2017; Daianu et al, 2016; Wang et al, 2016b; Wu et al, 2016), and functional MRI (Yang et al, 2016). Accurate prediction of AD progression still remains a challenging task due to the complicated characteristic of AD progression

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call